Stock BIO BIOFARM S.A.
Add to a list
To use this feature you must be a member
Log inSign up

Financials Biofarm S.A.

Equities

BIO

ROBIOFACNOR9

Pharmaceuticals

End-of-day quote Bucharest S.E.
Other stock markets
 06:00:00 2024-04-28 pm EDT 		5-day change 1st Jan Change
0.822 RON -0.48% Intraday chart for Biofarm S.A. -0.96% -0.24%
2023 Biofarm S.A. Reports Earnings Results for the Nine Months Ended September 30, 2023 CI
2023 Biofarm S.A. Reports Earnings Results for the Half Year Ended June 30, 2023 CI

Valuation

Fiscal Period: December 2017 2018 2019 2020 2021 2022
Capitalization 1 287.7 320.2 357.7 421.7 821.8 607
Enterprise Value (EV) 1 250.3 274.6 266.6 346.2 717.9 524.3
P/E ratio 8.51 x 8.9 x 7.53 x 8.34 x 14.7 x 9.31 x
Yield 6.51% 6.15% 5.79% 5.14% 2.88% 4.87%
Capitalization / Revenue 1.69 x 1.74 x 1.83 x 1.95 x 3.44 x 2.19 x
EV / Revenue 1.47 x 1.49 x 1.36 x 1.6 x 3 x 1.89 x
EV / EBITDA 5 x 4.69 x 3.86 x 4.64 x 8.69 x 5.55 x
EV / FCF 21.3 x 8.76 x 5.06 x -34.6 x 17.7 x -26.3 x
FCF Yield 4.7% 11.4% 19.8% -2.89% 5.64% -3.81%
Price to Book 1.33 x 1.42 x 1.39 x 1.45 x 2.47 x 1.6 x
Nbr of stocks (in thousands) 985,367 985,367 985,367 985,367 985,367 985,367
Reference price 2 0.2920 0.3250 0.3630 0.4280 0.8340 0.6160
Announcement Date 4/19/18 6/19/19 4/28/20 4/26/21 4/28/22 4/26/23
1RON in Million2RON
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: December 2017 2018 2019 2020 2021 2022
Net sales 1 170.2 184.2 195.3 216.4 239 277
EBITDA 1 50.08 58.56 69.14 74.62 82.59 94.45
EBIT 1 43.02 46.5 60.91 63.67 68.87 78.95
Operating Margin 25.27% 25.24% 31.18% 29.42% 28.81% 28.51%
Earnings before Tax (EBT) 1 42.68 47.17 62.47 64.85 69.55 80.88
Net income 1 36.03 38.42 50.88 54.26 60.36 70.92
Net margin 21.16% 20.86% 26.05% 25.07% 25.25% 25.6%
EPS 2 0.0343 0.0365 0.0482 0.0513 0.0569 0.0662
Free Cash Flow 1 11.78 31.34 52.69 -9.998 40.47 -19.96
FCF margin 6.92% 17.01% 26.97% -4.62% 16.93% -7.21%
FCF Conversion (EBITDA) 23.52% 53.51% 76.2% - 49% -
FCF Conversion (Net income) 32.69% 81.55% 103.55% - 67.06% -
Dividend per Share 2 0.0190 0.0200 0.0210 0.0220 0.0240 0.0300
Announcement Date 4/19/18 6/19/19 4/28/20 4/26/21 4/28/22 4/26/23
1RON in Million2RON
Estimates

Balance Sheet Analysis

Fiscal Period: December 2017 2018 2019 2020 2021 2022
Net Debt 1 - - - - - -
Net Cash position 1 37.4 45.6 91.1 75.5 104 82.7
Leverage (Debt/EBITDA) - - - - - -
Free Cash Flow 1 11.8 31.3 52.7 -10 40.5 -20
ROE (net income / shareholders' equity) 17.4% 17.4% 21.1% 19.8% 19.3% 19.9%
ROA (Net income/ Total Assets) 10.7% 10.6% 12% 11.1% 10.9% 11.1%
Assets 1 336.1 362.2 422.4 490.2 554.7 636.2
Book Value Per Share 2 0.2200 0.2300 0.2600 0.3000 0.3400 0.3900
Cash Flow per Share 2 0.0400 0.0500 0.0900 0.0600 0.1100 0.0800
Capex 1 19.4 20.9 19.8 27.5 21.5 30.1
Capex / Sales 11.37% 11.32% 10.13% 12.7% 8.97% 10.88%
Announcement Date 4/19/18 6/19/19 4/28/20 4/26/21 4/28/22 4/26/23
1RON in Million2RON
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Change in Enterprise Value/EBITDA

Sector Generic Pharmaceuticals

1st Jan change Capi.
BIOFARM S.A. Stock Biofarm S.A.
-0.24% 175M
SUN PHARMACEUTICAL INDUSTRIES LTD. Stock Sun Pharmaceutical Industries Ltd.
+20.81% 43.34B
OTSUKA HOLDINGS CO., LTD. Stock Otsuka Holdings Co., Ltd.
+20.44% 21.96B
SANDOZ GROUP AG Stock Sandoz Group AG
+13.30% 14.09B
CIPLA LIMITED Stock Cipla Limited
+12.97% 13.64B
ZYDUS LIFESCIENCES LIMITED Stock Zydus Lifesciences Limited
+39.74% 11.43B
ONO PHARMACEUTICAL CO., LTD. Stock Ono Pharmaceutical Co., Ltd.
-8.59% 6.86B
THE MEDICINES COMPANY Stock The Medicines Company
-0.05% 6.79B
STADA ARZNEIMITTEL Stock STADA Arzneimittel
-8.87% 5.73B
ASPEN PHARMACARE HOLDINGS LIMITED Stock Aspen Pharmacare Holdings Limited
+9.64% 5.22B
Generic Pharmaceuticals
  1. Stock Market
  2. Equities
  3. BIO Stock
  4. Financials Biofarm S.A.